The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer
Currently, lung cancer is a global problem and public health issue in the world. Chemoradiotherapy remains the optimal method in the treatment of patients with unresectable non-small cell lung cancer (NSCLC). Nowadays, immune response checkpoint inhibitors (monoclonal antibodies) are actively introd...
Saved in:
Main Authors: | E. I. Smolenov, G. V. Afonin, V. S. Usachev, D. D. Kudryavtsev, I. V. Kolobaev, S. A. Ivanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2021-06-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/727 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The predictive value of total body PET/CT in high PD-L1 expression and immunotherapy in advanced non-small cell lung cancer patients
by: Huibin Jin, et al.
Published: (2025-07-01) -
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01) -
Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
by: L. V. Bolotina, et al.
Published: (2022-04-01) -
Modern approaches to esophageal squamous cell carcinoma therapy: paradigm shift?
by: E. I. Smolenov, et al.
Published: (2023-12-01) -
Comparative efficacy of glioma treatment strategies: an umbrella review of meta-analyses
by: Erming Yang, et al.
Published: (2025-12-01)